Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FLUTAMIDE for Hormone-refractory prostate cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 12 adverse event reports in the FDA FAERS database where FLUTAMIDE was used for Hormone-refractory prostate cancer.

Most Reported Side Effects for FLUTAMIDE

Side Effect Reports % Deaths Hosp.
Dementia alzheimer's type 96 35.7% 0 0
Prostatic specific antigen increased 23 8.6% 1 9
Anaemia 21 7.8% 6 9
Decreased appetite 17 6.3% 0 4
Prostate cancer 14 5.2% 0 8
Asthenia 13 4.8% 0 0
Product use in unapproved indication 13 4.8% 0 0
Cough 12 4.5% 0 0
Drug ineffective 12 4.5% 2 0
Death 11 4.1% 11 1
Haematuria 11 4.1% 0 10
Pain in extremity 11 4.1% 0 1
Cardiac disorder 10 3.7% 0 0
Lacrimation increased 10 3.7% 0 0
Off label use 10 3.7% 0 1

Other Indications for FLUTAMIDE

Prostate cancer (169) Product used for unknown indication (31) Prostate cancer metastatic (11) Alopecia (7) Hormone therapy (6)

Other Drugs Used for Hormone-refractory prostate cancer

ENZALUTAMIDE (8,881) RADIUM RA-223 DICHLORIDE (1,615) ABIRATERONE (1,378) DOCETAXEL (674) LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN (579) DAROLUTAMIDE (553) CABAZITAXEL (524) PREDNISONE (474) APALUTAMIDE (365) OLAPARIB (313)

Related Pages

FLUTAMIDE Full Profile All Hormone-refractory prostate cancer Drugs FLUTAMIDE Demographics FLUTAMIDE Timeline